Prime Minister’s Office:
Prime Minister Shri Narendra Modi today interacted with a Group of Doctors from across the country, via video conferencing, to discuss the Covid related situation.
Prime Minister thanked the entire medical fraternity & the paramedical staff for the exemplary fight displayed by them against the extraordinary circumstances of the second wave of Covid, adding that the entire country is indebted to them.
He noted that be it testing, supply of medicines or set-up of new infrastructure in record time, all these are being done at a fast pace.
Several challenges of oxygen production and supply are being overcome. The steps taken by the country to augment human resources, like including MBBS students in Covid treatment, and ASHAs and Anganwadi workers in rural areas, provided extra support to the health system.
Prime Minister underlined that the strategy of starting vaccination programme with front line warriors has paid rich dividends in the second wave.
About 90% of the health professionals in the country have already taken the first dose. Vaccines have ensured safety of most of the doctors.
Prime Minister urged doctors to include oxygen audit in their daily efforts. Noting that a large number of patients are undergoing treatment in ‘home isolation’, he requested the doctors to ensure that the home based care of every patient is SOP driven.
He said that telemedicine has played a big role for patients in home isolation, and this service needs to be expanded in rural areas as well.
He lauded the doctors who are forming teams and providing telemedicine service in villages. He appealed to doctors across the states to form similar teams, train final year MBBS students and MBBS interns, and work towards ensuring that all tehsils and districts of the country have telemedicine service.
Prime Minister also discussed the challenge of Mucormycosis and said that doctors may need to put in extra effort towards taking active steps and spreading awareness about it.
He further underscored the importance of psychological care, along with the importance of physical care. He said that continuously fighting this long battle against the virus must be mentally challenging for the medical fraternity, but the power of faith of citizens stands with them in this fight.
During the interaction, the Doctors thanked the Prime Minister for his guidance and leadership during the recent surge of cases.
Doctors thanked the Prime Minister for prioritising the health care workers for vaccination. They informed the Prime Minister about their preparedness since the first wave of Covid and the challenges they faced in the second wave.
The doctors shared their experiences, best practices and the innovative efforts. They informed that in the fight against Covid, every effort is also being made to take proper care of non-Covid patients.
They also shared their experiences of increasing awareness among the public, including about sensitising patients against improper use of medicines.
The meeting was attended by Member (Health) NITI Aayog, Health Secretary, Pharmaceutical Secretary and other officers from PMO, Ministries and Departments of Central Government.
Defence Minister Rajnath Singh along with Union Health Minister Dr Harsh Vardhan releases the first batch of Anti Covid drug ‘2DG’.
The drug has been developed by DRDO’s Institute of Nuclear Medicine & Allied Sciences (INMAS) in collaboration with Dr Reddy’s Laboratories.
I would say that this drug is a new ray of hope for all of us.
But right now, nor can we relax not is the time to get tired and stop. Because this wave has come for the second time, and there is nothing definite about this too. We have to take steps with full caution.
We have always taken the situation quite seriously. Whether it is oxygen supply, or medicines, ICU beds or arranging cryogenic tankers, a collective effort has always been made which has yielded good results.
Bleeding and clotting cases following COVID vaccination in India are minuscule and in line with the expected number of diagnoses of these conditions in the country, a report submitted by the National AEFI (Adverse Event Following Immunization) Committee to the Ministry of Health & Family Welfare said.
Alerts have been raised in some countries on post-vaccination “embolic and thrombotic events” on 11 March 2021 particularly with AstraZeneca-Oxford vaccine [Covishield in India].
A decision was taken to conduct an urgent in-depth analysis of the adverse events (AE) in India in the light of the global concerns.
The National AEFI committee noted that as of 03 April 2021, 75,435,381 vaccine doses had been administered (Covishield – 68,650,819; Covaxin – 6,784,562).
Of these, 65,944,106 were first doses and 9,491,275 second dose.
Since the COVID-19 vaccination drive was initiated – more than 23,000 adverse events were reported through the CO-WIN platform reported from 684 of the 753 districts of the country.
Of these, only 700 cases (@ 9.3 cases /million doses administered) were reported to be serious and severe nature.
The AEFI Committee has completed an in-depth case review of 498 serious and severe events, of which 26 cases have been reported to be potential thromboembolic (formation of a clot in a blood vessel that might also break loose and carried by the blood stream to plug another vessel) events – following the administration of Covishield vaccine – with a reporting rate of 0.61 cases/ million doses.
There were no potential thromboembolic events reported following administration of Covaxin vaccine.
AEFI data in India showed that there is a very miniscule but definitive risk of thromboembolic events.
The reporting rate of these events in India is around 0.61/million doses, which is much lower than the 4 cases/million reported by UK’s regulator Medical and Health Regulatory Authority (MHRA). Germany has reported 10 events per million doses.
It is important to know that thromboembolic events keep occurring in general population as background and scientific literature suggests that this risk is almost 70 per cent less in persons of South and South East Asian descent in comparison to those from European descent.
MOHFW is separately issuing advisories to Healthcare Workers and Vaccine Beneficiaries to encourage people to be aware of suspected thromboembolic symptoms occurring within 20 days after receiving any COVID-19 vaccine (particularly Covishield) and report preferably to the health facility where vaccine was administered:
- pain in chest;
- pain in limbs/pain on pressing limbs or swelling in limbs (arm or calf);
- multiple, pinhead size red spots or bruising of skin in an area beyond the injection site;
- persistent abdominal pain with or without vomiting;
- seizures in the absence of previous history of seizures with or without vomiting;
- severe and persistent headache with or without vomiting (in the absence of previous history of migraine or chronic headache);
- weakness/paralysis of limbs or any particular side or part of the body (including face);
- persistent vomiting without any obvious reason;
- blurred vision or pain in eyes or having double vision;
- change in mental status or having confusion or depressed level of consciousness
- Any other symptom or health condition which is of concern to the recipient or the family
Covishield, the COVID-19 vaccine, continues to have a definite positive benefit risk profile with tremendous potential to prevent infections and reduce deaths due to COVID-19 across the world and in India. Over 13.4 crore doses of Covishield vaccine have been administered as on 27 April 2021 in India.
MoHFW is continuously monitoring the safety of all COVID-19 vaccines and is promoting reporting of suspected adverse events.
Department of Pharmaceuticals intensified monitoring of availability, production and supply of drugs used for Covid-19 Treatment in early April, 2021 as number of cases of Covid-19 started increasing steeply.
Remdesivir is a patented drug, manufactured in India under voluntary licenses granted by Gilead Life Sciences USA, the patent holder, to 7 Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab., Hetero, Jubilant Pharma, Mylan, Syngene and Zydus Cadila).
To augment the domestic production capacity, all the seven domestic licensed manufacturers of Remdesivir were asked to ramp up production quickly.
With combined efforts of the central government and the manufacturing companies, the production capacity of the licensed manufacturers has increased unprecedentedly from 38 lakh vials per month to nearly 119 lakh vials per month.
With accelerated approval of 38 additional manufacturing sites, the number of approved manufacturing sites of Remdesivir in country has increased from 22 sites to 60 sites.
With the help of Ministry of External Affairs, the manufacturers of Remdesivir are being facilitated for getting supplies of requisite raw materials and equipments from foreign countries.
All efforts are being made to enhance the availability of the drug both through imports as well as augmented domestic production.
Exports of Remdesiver has been prohibited since 11th April, 2021. Customs duty has been exempted on Remdesivir injection, Remdesivir API and Beta Cyclodextrin (SBEBCD) used in the manufacture of Remdesivir with effect from 20th April 2021.
Looking to the suddenly increased demand in the country, in order to ensure equitable distribution of Remdesivir among different regions of the country, central government has been making allocations to States and UTs since third week of April.
All the seven Indian manufacturers have been making supplies to States as per the allocation both against government purchase orders and also through their private distribution channels in States.
Total 54.15 lakh vials of Remdesivir have been supplied across the country by the Drug companies during 21st April-15th May, 2021 period.
In addition to allocation mentioned above, as on 16.05.2021, a total of 5.26 lakh vials of Remdesivir, which have been received through donation from other countries/organizations and 40000 vials which have been commercially imported, have also been allocated to States and UTs.
Daily average of COVID19 +ve cases from 1 to 8 May was 37, 144. Down to 35,919 in the last week.
10% – 30% decrease in 8 districts.
Active cases down from 4,45,000 to 3,62,315.
Lockdown will bear fruit. Let us continue to be cautious. We shall overcome!
I am delighted with the virtual meeting with our GIA partners to discuss COVID19 pandemic and how other countries are managing the crisis.
We live by the ideals of Vasudhaiva Kutumbakam & there is no better time to follow and practice this for international cooperation.
Last year, our government acted swiftly, adopting the 5T policy strategy: trace, track, test, treat, and technology.
The government of Karnataka pioneered this and implemented it effectively to contain and control the number of cases in 2020.
The second wave of the virus hit the state about 4-5 weeks ago. The government swung into action to form a task force and appointed me to steer it. We have also enhanced hospital infrastructure across the state.
The Government of Karnataka is committed to building a healthcare resilient state. Our vision is to create sophisticated, multi-speciality hospitals in every nook and corner of the state with the best healthcare facilities.
I extend a warm welcome to corporations and organisations willing to work with us to enhance healthcare infrastructure in the state.
Karnataka is one of the most progressive and industrialised states of India. We would be more than happy to explore areas for collaboration.
Launched the vaccination drive for 18-44 years age group in all the Districts of Manipur today.N Biren Singh – Chief Minister, Manipur
I also appeal my young friends to look out for people who might need your help in registration for vaccination.
Dr Pramod Sawant, Chief Minister, Goa :
Spoke to the Union Home Minister Amit Shah ji regarding the impact and devastation caused by the Tauktae cyclone in the state of Goa.
Hon’ble Home Minister inquired about the widespread damage caused by the cyclone in the state and assured full support of all Central agencies to the State for returning to normalcy.
We will provide all necessary assistance to Goans impacted by the cyclone.
Abhishek Singhvi, National Spokesperson, Congress :
Clear indicators of Mala fides of central Govt & CBI regarding West Bengal arrests. Necessity of arrest must exist before arresting. Power of arrest never means obligation to arrest.
Narada is a decade old; even tapes are of 2016; matter also came to Supreme Court; why necessity/urgency to arrest Now.
Grave doubt if Governor, whose partisan conduct is clear, merely because he swore in Minsters in 2011, has exclusive power to grant sanction!
Why sanction after 5yrs of 2016 tapes &sudden arrests in 2021. Bad West Bengal election losers? Vendetta? Electoral verdict to be reversed?
As MLA’s, West Bengal arrestees cannot be proceeded against without Speaker’s sanction.
Hence lack of jurisdiction plus vindictive arrests plus timing of arrests, all smack of, steeped in & clearly proves cheapest & most vile vendetta!
Pema Khandu, Chief Minister Arunachal Pradesh :
Chaired the 23rd State Board for Wildlife meeting and cleared important development proposals and recommended to NBWL.
Issues relating to strengthening our efforts to protect wildlife were discussed at length and key decisions taken.
A fine balance between development & protection of our rich forest resources was the key take away.
CCAs are example of community taking lead in forest conservation. A state policy for encouraging all such initiatives will be taken up by constituting a committee.
Western Arunachal & Eastern Bhutan have similar landscape. A trans National initiative for coordinated conservation will be explored.
Also welcomed the newly appointed members of the SBWL & exhorted them to work with full dedication for protection our rich biodiversity.
Seeing love inside you that is meditation:
Pic Credit:Sri Sri